Explore
Validate
Learn
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [6]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 14914-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#14914-1-AP, RRID:AB_10863118
- Product name
- HN1 antibody
- Antibody type
- Polyclonal
- Description
- KD/KO validated HN1 antibody (Cat. #14914-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: IHC, IP, WB,ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Knocking Down HN1 Blocks Helicobacter pylori-Induced Malignant Phenotypes in Gastric Mucosal Cells and Inhibits Gastric Cancer Cell Proliferation, Cytoskeleton Remodeling, and Migration.
Hematological and Neurological Expressed 1 Promotes Tumor Progression Through mTOR Signaling in Ovarian Cancer.
Epigenetic inhibition of CTCF by HN1 promotes dedifferentiation and stemness of anaplastic thyroid cancer.
Matrine exerts an anti-tumor effect via regulating HN1 in triple breast cancer both in vitro and in vivo.
HN1 promotes tumor growth and metastasis of anaplastic thyroid carcinoma by interacting with STMN1.
Increased expression of hematological and neurological expressed 1 (HN1) is associated with a poor prognosis of hepatocellular carcinoma and its knockdown inhibits cell growth and migration partly by down-regulation of c-Met.
Huang Y, Wang X, Liu H, Meng X, Yin H, Hou R, Lin W, Zhang X, Ma J, Zhang X, Zhang F, Miao Y
Biochemical genetics 2024 Mar 25;
Biochemical genetics 2024 Mar 25;
Hematological and Neurological Expressed 1 Promotes Tumor Progression Through mTOR Signaling in Ovarian Cancer.
Li P, Qian LH, Liao YN, Gai YZ, Pan H, Han L, Nie HZ
Reproductive sciences (Thousand Oaks, Calif.) 2024 Jul;31(7):1868-1880
Reproductive sciences (Thousand Oaks, Calif.) 2024 Jul;31(7):1868-1880
Epigenetic inhibition of CTCF by HN1 promotes dedifferentiation and stemness of anaplastic thyroid cancer.
Pan Z, Lu X, Xu T, Chen J, Bao L, Li Y, Gong Y, Che Y, Zou X, Tan Z, Huang P, Ge M
Cancer letters 2024 Jan 1;580:216496
Cancer letters 2024 Jan 1;580:216496
Matrine exerts an anti-tumor effect via regulating HN1 in triple breast cancer both in vitro and in vivo.
Guo Q, Yu Y, Tang W, Zhou S, Lv X
Chemical biology & drug design 2023 Dec;102(6):1469-1477
Chemical biology & drug design 2023 Dec;102(6):1469-1477
HN1 promotes tumor growth and metastasis of anaplastic thyroid carcinoma by interacting with STMN1.
Pan Z, Fang Q, Li L, Zhang Y, Xu T, Liu Y, Zheng X, Tan Z, Huang P, Ge M
Cancer letters 2021 Mar 31;501:31-42
Cancer letters 2021 Mar 31;501:31-42
Increased expression of hematological and neurological expressed 1 (HN1) is associated with a poor prognosis of hepatocellular carcinoma and its knockdown inhibits cell growth and migration partly by down-regulation of c-Met.
Chen JJ, Sun X, Mao QQ, Jiang XY, Zhao XG, Xu WJ, Zhong L
The Kaohsiung journal of medical sciences 2020 Mar;36(3):196-205
The Kaohsiung journal of medical sciences 2020 Mar;36(3):196-205
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The HN1 antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human HN1. This antibody recognizes human, mouse, rat antigen. The HN1 antibody has been validated for the following applications: ELISA, WB analysis.
